Glucagon-like peptide-1 receptor agonist use corresponded with risk reductions for dozens of diseases and adverse health ...
For people with diabetes, the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a reduc ...
A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback